PFE logo

Pfizer (PFE) Cash from investing

annual CFI:

$2.65B+$34.93B(+108.22%)
December 31, 2024

Summary

  • As of today (May 29, 2025), PFE annual cash flow from investing activities is $2.65 billion, with the most recent change of +$34.93 billion (+108.22%) on December 31, 2024.
  • During the last 3 years, PFE annual CFI has risen by +$25.20 billion (+111.76%).
  • PFE annual CFI is now -56.91% below its all-time high of $6.15 billion, reached on December 31, 2012.

Performance

PFE Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

quarterly CFI:

$3.27B+$4.90B(+301.73%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE quarterly cash flow from investing activities is $3.27 billion, with the most recent change of +$4.90 billion (+301.73%) on March 29, 2025.
  • Over the past year, PFE quarterly CFI has increased by +$1.54 billion (+89.03%).
  • PFE quarterly CFI is now -66.13% below its all-time high of $9.67 billion, reached on March 1, 2018.

Performance

PFE quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

TTM CFI:

$4.19B+$1.54B(+58.14%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE TTM cash flow from investing activities is $4.19 billion, with the most recent change of +$1.54 billion (+58.14%) on March 29, 2025.
  • Over the past year, PFE TTM CFI has increased by +$38.05 billion (+112.39%).
  • PFE TTM CFI is now -31.85% below its all-time high of $6.15 billion, reached on December 31, 2012.

Performance

PFE TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

PFE Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+108.2%+89.0%+112.4%
3 y3 years+111.8%+477.4%+120.7%
5 y5 years+167.2%+4711.3%+136.3%

PFE Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+108.2%-28.8%+112.8%at high+112.4%
5 y5-yearat high+108.2%-60.7%+112.8%at high+112.4%
alltimeall time-56.9%+108.2%-66.1%+112.8%-31.9%+112.4%

PFE Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$3.27B(-301.7%)
$4.19B(+58.1%)
Dec 2024
$2.65B(-108.2%)
-$1.62B(-21.1%)
$2.65B(-139.5%)
Sep 2024
-
-$2.06B(-144.7%)
-$6.72B(+78.0%)
Jun 2024
-
$4.60B(+165.6%)
-$3.78B(-88.8%)
Mar 2024
-
$1.73B(-115.8%)
-$33.86B(+4.9%)
Dec 2023
-$32.28B(+104.5%)
-$11.00B(-1338.3%)
-$32.28B(+25.6%)
Sep 2023
-
$888.00M(-103.5%)
-$25.69B(-5.6%)
Jun 2023
-
-$25.48B(-868.8%)
-$27.21B(+108.7%)
Mar 2023
-
$3.31B(-175.2%)
-$13.04B(-17.4%)
Dec 2022
-$15.78B(-30.0%)
-$4.41B(+603.3%)
-$15.78B(+13.1%)
Sep 2022
-
-$627.00M(-94.5%)
-$13.96B(-40.4%)
Jun 2022
-
-$11.31B(-2095.2%)
-$23.41B(+15.7%)
Mar 2022
-
$567.00M(-121.9%)
-$20.23B(-10.3%)
Dec 2021
-$22.55B(+427.9%)
-$2.59B(-74.3%)
-$22.55B(+93.9%)
Sep 2021
-
-$10.08B(+23.8%)
-$11.63B(+983.9%)
Jun 2021
-
-$8.14B(+365.8%)
-$1.07B(-82.0%)
Mar 2021
-
-$1.75B(-121.0%)
-$5.95B(+39.2%)
Dec 2020
-$4.27B(+8.3%)
$8.33B(+1631.8%)
-$4.27B(-72.3%)
Sep 2020
-
$481.00M(-103.7%)
-$15.43B(-31.9%)
Jun 2020
-
-$13.01B(>+9900.0%)
-$22.68B(+96.0%)
Mar 2020
-
-$71.00M(-97.5%)
-$11.57B(+193.2%)
Dec 2019
-$3.94B(-187.2%)
-$2.83B(-58.1%)
-$3.94B(+110.3%)
Sep 2019
-
-$6.76B(+255.4%)
-$1.88B(-194.7%)
Jun 2019
-
-$1.90B(-125.2%)
$1.98B(-17.8%)
Mar 2019
-
$7.55B(-1088.2%)
$2.41B(-46.8%)
Dec 2018
$4.53B(-195.5%)
-$764.00M(-73.7%)
$4.53B(+753.8%)
Sep 2018
-
-$2.90B(+97.0%)
$530.00M(+25.3%)
Jun 2018
-
-$1.47B(-115.2%)
$423.00M(+166.0%)
Mar 2018
-
$9.67B(-303.1%)
$159.00M(-103.4%)
Dec 2017
-$4.74B(-39.2%)
-$4.76B(+58.1%)
-$4.74B(+54.5%)
Sep 2017
-
-$3.01B(+73.2%)
-$3.07B(-30.9%)
Jun 2017
-
-$1.74B(-136.5%)
-$4.44B(-39.8%)
Mar 2017
-
$4.77B(-254.5%)
-$7.38B(-5.3%)
Dec 2016
-$7.79B(+161.4%)
-$3.09B(-29.5%)
-$7.79B(+12.5%)
Sep 2016
-
-$4.38B(-6.3%)
-$6.93B(-11.1%)
Jun 2016
-
-$4.68B(-207.4%)
-$7.79B(+49.3%)
Mar 2016
-
$4.36B(-295.8%)
-$5.22B(+75.1%)
Dec 2015
-$2.98B(-47.3%)
-$2.22B(-57.6%)
-$2.98B(+31.3%)
Sep 2015
-
-$5.24B(+149.1%)
-$2.27B(-618.3%)
Jun 2015
-
-$2.10B(-131.9%)
$438.00M(-57.7%)
Mar 2015
-
$6.59B(-535.4%)
$1.04B(-118.3%)
Dec 2014
-$5.65B(-46.4%)
-$1.51B(-40.3%)
-$5.65B(+41.4%)
Sep 2014
-
-$2.54B(+68.2%)
-$4.00B(+93.5%)
Jun 2014
-
-$1.51B(+1437.8%)
-$2.07B(-827.5%)
Mar 2014
-
-$98.00M(-169.0%)
$284.00M(-102.7%)
Dec 2013
-$10.54B(-271.3%)
$142.00M(-123.5%)
-$10.54B(+173.9%)
Sep 2013
-
-$603.00M(-171.5%)
-$3.85B(+10.2%)
Jun 2013
-
$843.00M(-107.7%)
-$3.49B(-33.1%)
Mar 2013
-
-$10.93B(-259.8%)
-$5.22B(-184.9%)
Dec 2012
$6.15B(+233.9%)
$6.84B(-2868.0%)
$6.15B(-4464.5%)
Sep 2012
-
-$247.00M(-72.2%)
-$141.00M(-143.9%)
Jun 2012
-
-$887.00M(-296.7%)
$321.00M(-79.5%)
Mar 2012
-
$451.00M(-16.8%)
$1.57B(-14.9%)
Dec 2011
$1.84B(-474.6%)
$542.00M(+152.1%)
$1.84B(-142.4%)
Sep 2011
-
$215.00M(-40.4%)
-$4.34B(-48.5%)
Jun 2011
-
$361.00M(-50.2%)
-$8.44B(-7.9%)
Mar 2011
-
$725.00M(-112.8%)
-$9.16B(+1762.0%)
Dec 2010
-$492.00M(-98.4%)
-$5.64B(+45.5%)
-$492.00M(-162.6%)
Sep 2010
-
-$3.88B(+974.8%)
$786.00M(-82.0%)
Jun 2010
-
-$361.00M(-103.8%)
$4.37B(-153.0%)
Mar 2010
-
$9.39B(-315.1%)
-$8.24B(-73.6%)
Dec 2009
-$31.27B(+143.6%)
-$4.37B(+1365.4%)
-$31.27B(+5.3%)
Sep 2009
-
-$298.00M(-97.7%)
-$29.68B(-2.7%)
Jun 2009
-
-$12.97B(-4.8%)
-$30.49B(+45.3%)
Mar 2009
-
-$13.63B(+390.4%)
-$20.98B(+63.5%)
Dec 2008
-$12.84B(-1714.5%)
-$2.78B(+151.1%)
-$12.84B(-0.1%)
Sep 2008
-
-$1.11B(-68.0%)
-$12.85B(+9.9%)
Jun 2008
-
-$3.46B(-36.8%)
-$11.70B(+30.6%)
Mar 2008
-
-$5.48B(+95.9%)
-$8.96B(-1227.0%)
Dec 2007
$795.00M
-$2.80B(-6055.3%)
$795.00M(-80.3%)
Sep 2007
-
$47.00M(-106.5%)
$4.03B(-6.9%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$724.00M(-117.0%)
$4.33B(+9.8%)
Mar 2007
-
$4.27B(+881.8%)
$3.94B(-22.7%)
Dec 2006
$5.10B(-200.6%)
$435.00M(+26.5%)
$5.10B(-263.9%)
Sep 2006
-
$344.00M(-131.0%)
-$3.11B(-36.7%)
Jun 2006
-
-$1.11B(-120.4%)
-$4.92B(-260.5%)
Mar 2006
-
$5.43B(-169.8%)
$3.06B(-160.4%)
Dec 2005
-$5.07B(-46.2%)
-$7.78B(+432.1%)
-$5.07B(<-9900.0%)
Sep 2005
-
-$1.46B(-121.3%)
$18.00M(-98.8%)
Jun 2005
-
$6.87B(-354.1%)
$1.52B(-118.0%)
Mar 2005
-
-$2.71B(+0.6%)
-$8.41B(-10.8%)
Dec 2004
-$9.42B(-294.3%)
-$2.69B(-7367.6%)
-$9.42B(+61.8%)
Sep 2004
-
$37.00M(-101.2%)
-$5.82B(+1.2%)
Jun 2004
-
-$3.05B(-18.1%)
-$5.75B(-291.0%)
Mar 2004
-
-$3.72B(-508.5%)
$3.01B(-37.9%)
Dec 2003
$4.85B(-211.8%)
$911.00M(+759.4%)
$4.85B(+46.8%)
Sep 2003
-
$106.00M(-98.1%)
$3.30B(+37.7%)
Jun 2003
-
$5.72B(-403.6%)
$2.40B(-146.2%)
Mar 2003
-
-$1.88B(+196.1%)
-$5.19B(+19.7%)
Dec 2002
-$4.34B(-39.2%)
-$636.00M(-20.4%)
-$4.34B(-23.5%)
Sep 2002
-
-$799.00M(-57.3%)
-$5.67B(-9.9%)
Jun 2002
-
-$1.87B(+81.8%)
-$6.29B(-8.9%)
Mar 2002
-
-$1.03B(-47.6%)
-$6.91B(-3.2%)
Dec 2001
-$7.13B(+90.1%)
-$1.97B(+38.0%)
-$7.13B(+28.3%)
Sep 2001
-
-$1.42B(-42.7%)
-$5.56B(-8.1%)
Jun 2001
-
-$2.49B(+97.5%)
-$6.06B(+54.1%)
Mar 2001
-
-$1.26B(+220.4%)
-$3.93B(+4.7%)
Dec 2000
-$3.75B(-3.9%)
-$393.00M(-79.5%)
-$3.75B(+12.5%)
Sep 2000
-
-$1.92B(+429.6%)
-$3.33B(-0.9%)
Jun 2000
-
-$362.00M(-66.5%)
-$3.37B(-15.1%)
Mar 2000
-
-$1.08B(-4424.0%)
-$3.96B(+1.5%)
Dec 1999
-$3.91B(+408.6%)
$25.00M(-101.3%)
-$3.91B(-33.5%)
Sep 1999
-
-$1.95B(+102.6%)
-$5.88B(+137.6%)
Jun 1999
-
-$961.00M(-6.1%)
-$2.47B(+26.9%)
Mar 1999
-
-$1.02B(-47.5%)
-$1.95B(+153.9%)
Dec 1998
-$768.00M(-20.2%)
-$1.95B(-233.6%)
-$768.00M(-179.5%)
Sep 1998
-
$1.46B(-433.4%)
$966.00M(-246.1%)
Jun 1998
-
-$437.00M(-374.8%)
-$661.00M(+39.7%)
Mar 1998
-
$159.00M(-174.6%)
-$473.00M(-50.9%)
Dec 1997
-$963.00M(+13.3%)
-$213.00M(+25.3%)
-$963.00M(+124.5%)
Sep 1997
-
-$170.00M(-31.7%)
-$429.00M(-61.5%)
Jun 1997
-
-$249.00M(-24.8%)
-$1.11B(-23.0%)
Mar 1997
-
-$331.00M(-203.1%)
-$1.45B(+70.1%)
Dec 1996
-$850.00M(-63.7%)
$321.00M(-137.6%)
-$850.00M(-44.2%)
Sep 1996
-
-$854.00M(+46.7%)
-$1.52B(+116.8%)
Jun 1996
-
-$582.00M(-319.6%)
-$702.50M(+69.8%)
Mar 1996
-
$265.00M(-175.2%)
-$413.70M(-82.3%)
Dec 1995
-$2.34B(+178.8%)
-$352.20M(+957.7%)
-$2.34B(+7.8%)
Sep 1995
-
-$33.30M(-88.6%)
-$2.17B(-5.8%)
Jun 1995
-
-$293.20M(-82.4%)
-$2.31B(-4.7%)
Mar 1995
-
-$1.66B(+809.3%)
-$2.42B(+188.2%)
Dec 1994
-$840.30M(+326.8%)
-$183.00M(+9.8%)
-$840.30M(+47.3%)
Sep 1994
-
-$166.60M(-59.1%)
-$570.30M(+31.9%)
Jun 1994
-
-$407.80M(+391.9%)
-$432.50M(-2199.5%)
Mar 1994
-
-$82.90M(-195.3%)
$20.60M(-110.5%)
Dec 1993
-$196.90M(-150.5%)
$87.00M(-402.1%)
-$196.90M(-413.0%)
Sep 1993
-
-$28.80M(-163.6%)
$62.90M(-169.5%)
Jun 1993
-
$45.30M(-115.1%)
-$90.50M(+3.2%)
Mar 1993
-
-$300.40M(-186.6%)
-$87.70M(-122.5%)
Dec 1992
$389.90M(-411.4%)
$346.80M(-290.3%)
$389.90M(+124.6%)
Sep 1992
-
-$182.20M(-478.8%)
$173.60M(-17.4%)
Jun 1992
-
$48.10M(-72.9%)
$210.10M(-555.7%)
Mar 1992
-
$177.20M(+35.8%)
-$46.10M(-63.2%)
Dec 1991
-$125.20M(-61.9%)
$130.50M(-189.6%)
-$125.20M(-46.1%)
Sep 1991
-
-$145.70M(-30.0%)
-$232.10M(-32.6%)
Jun 1991
-
-$208.10M(-312.1%)
-$344.60M(+4.7%)
Mar 1991
-
$98.10M(+315.7%)
-$329.10M(+0.0%)
Dec 1990
-$329.00M(-47.5%)
$23.60M(-109.1%)
-$329.00M(-6.7%)
Sep 1990
-
-$258.20M(+34.1%)
-$352.60M(+273.5%)
Jun 1990
-
-$192.60M(-296.1%)
-$94.40M(-196.1%)
Mar 1990
-
$98.20M
$98.20M
Dec 1989
-$626.80M
-
-

FAQ

  • What is Pfizer annual cash flow from investing activities?
  • What is the all time high annual CFI for Pfizer?
  • What is Pfizer annual CFI year-on-year change?
  • What is Pfizer quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Pfizer?
  • What is Pfizer quarterly CFI year-on-year change?
  • What is Pfizer TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Pfizer?
  • What is Pfizer TTM CFI year-on-year change?

What is Pfizer annual cash flow from investing activities?

The current annual CFI of PFE is $2.65B

What is the all time high annual CFI for Pfizer?

Pfizer all-time high annual cash flow from investing activities is $6.15B

What is Pfizer annual CFI year-on-year change?

Over the past year, PFE annual cash flow from investing activities has changed by +$34.93B (+108.22%)

What is Pfizer quarterly cash flow from investing activities?

The current quarterly CFI of PFE is $3.27B

What is the all time high quarterly CFI for Pfizer?

Pfizer all-time high quarterly cash flow from investing activities is $9.67B

What is Pfizer quarterly CFI year-on-year change?

Over the past year, PFE quarterly cash flow from investing activities has changed by +$1.54B (+89.03%)

What is Pfizer TTM cash flow from investing activities?

The current TTM CFI of PFE is $4.19B

What is the all time high TTM CFI for Pfizer?

Pfizer all-time high TTM cash flow from investing activities is $6.15B

What is Pfizer TTM CFI year-on-year change?

Over the past year, PFE TTM cash flow from investing activities has changed by +$38.05B (+112.39%)
On this page